glp-1 and cancer receptor agonists in the context of cancer: the road ahead GLP-1s tied to lower risk

This targeted escalation ensures resources are allocated efficiently while improving outcomes

Vijay has six years of scientific research experience at renowned research institutes such as the Indian Council for Agricultural Research and KIIT University

compounded alternatives through PlexusDx Weight Management Protocols offer a separate pricing structure published on the relevant product pages

1 and Supplementary Table S2

Competing interests Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)